nm21-1480
numab
['ca,022,1', 'ca,022,i']
at #sitc2022, numab presents phase 1 dose escalation results of nm21-1480, its anti-pd-l1x4-1bb checkpoint modulator. learn more from our team in person in boston and check out the poster: 